Evidence map›Paper›PMID 38695461›Full record

ArticleCadernos de saude publica2024

[Overview of long COVID in Brazil: a preliminary analysis of a survey to think about health policies].

Karina Barros Calife Batista, Michelle Vieira Fernandez, Lorena Guadalupe Barberia, Erica Tatiane da Silva, Vaneide Daciane Pedi, Bárbara Maia Lima Madeira Pontes, Gui Araujo, Rafael da Silveira Moreira, Marcos Pedrosa, Mariana Pastorello Verotti and 3 more

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Cadernos de saude publica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Symptoms of long COVID in children and adolescents: a scoping review.Revista da Escola de Enfermagem da U S P · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Karina Barros Calife BatistaFaculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil.ORCID 0000-0002-7038-8069
Michelle Vieira FernandezUniversidade de Brasília, Brasília, Brasil.ORCID 0000-0003-0224-0991
Lorena Guadalupe BarberiaFaculdade de Filosofia, Letras e Ciências Humanas, Universidade de São Paulo, São Paulo, Brasil.ORCID 0000-0001-6319-543X
Erica Tatiane da SilvaFiocruz Brasília, Fundação Oswaldo Cruz, Brasília, Brasil.ORCID 0000-0001-6478-3532
Vaneide Daciane PediFiocruz Brasília, Fundação Oswaldo Cruz, Brasília, Brasil.ORCID 0000-0003-4294-7238
Bárbara Maia Lima Madeira PontesUniversidade de Brasília, Brasília, Brasil.ORCID 0000-0002-7127-2498
Gui AraujoSwansea University, Swansea, U. K.ORCID 0000-0001-8131-1553
Rafael da Silveira MoreiraInstituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Brasil.ORCID 0000-0003-0079-2901
Marcos PedrosaInstituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Brasil.ORCID 0000-0002-4633-2567
Mariana Pastorello VerottiFiocruz Brasília, Fundação Oswaldo Cruz, Brasília, Brasil.ORCID 0000-0003-3732-372X
Claudio Maierovitch Pessanha HenriquesFiocruz Brasília, Fundação Oswaldo Cruz, Brasília, Brasil.ORCID 0000-0002-1461-7082
Anna Catharina FlorêncioInstituto de Medicina Integral Professor Fernando Figueira, Recife, Brasil.ORCID 0000-0003-1281-192X
Melania Maria Ramos de AmorimInstituto de Medicina Integral Professor Fernando Figueira, Recife, Brasil.ORCID 0000-0003-1047-2514
Fundação Oswaldo Cruz · BRInstituto de Medicina Integral Professor Fernando Figueira · BRUniversidade de Brasília · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRMinistério da Saúde · ST

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Characterized by symptoms that remain or appear for the first time within three months of SARS-CoV-2 infection, long COVID can manifest itself in different ways, including in non-hospitalized or asymptomatic cases. Thus, this study offers an overview of long COVID in Brazil, especially of its diagnosis, symptoms, and challenges for new health management. Data from a study that investigated long COVID in people affected by COVID-19 were used. These original data stem from a survey with adult Brazilians (aged 18 years or older) who had COVID-19 that collected information from March 14 to April 14, 2022, by a questionnaire on social media. The questionnaire addressed sociodemographic characteristics, history of COVID-19 infections, vaccination against the disease, investigation of health status and quality of life before and after COVID-19, and search and access to treatment. Of the 1,728 respondents, 720 were considered eligible for analysis, of which 496 (69%) had long COVID. Individuals with long COVID reported clinical manifestations such as anxiety (80%), memory loss (78%), generalized pain (77%), lack of attention (75%), fatigue (73%), hair loss (71%), sleep changes (70%), mood swings (62%), malaise (60%), and joint pain (59%). Most sought health services during and after the acute phase of COVID-19 (94 and 80%, respectively), representing the need to structure the healthcare system for these patients.

Indexed as

COVID-19Health PolicyPost-Acute COVID-19 SyndromeAdolescentAdultAgedBrazilFemaleHumansMaleMiddle AgedQuality of LifeSARS-CoV-2Socioeconomic FactorsSurveys and QuestionnairesYoung Adult

Identifiers

PMID38695461
PMCPMC11057476
OpenAlexW4396658703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.